This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 18 print issues and online access
$259.00 per year
only $14.39 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
Viggiano P, Boscia G, Clemente A, Laterza M, Termite AC, Pignataro MG, et al. Photobiomodulation-induced choriocapillaris perfusion enhancement and outer retinal remodelling in intermediate age-related macular degeneration: a promising therapeutic approach with short-term results. EYE. 2025;39:2057–63. https://doi.org/10.1038/s41433-025-03805-2.
Nassisi M, Mainetti C, Paparella GR, Belloni Baroni L, Milella P, Leone G, et al. Short-term efficacy of photobiomodulation in early and intermediate age-related macular degeneration: the PBM4AMD study. EYE. 2024;38:3467–72. https://doi.org/10.1038/s41433-024-03326-4.
Boyer D, Hu A, Warrow D, Xavier S, Gonzalez V, Lad E, et al. LIGHTSITE III: 13-month efficacy and safety evaluation of multiwavelength photobiomodulation in nonexudative (dry) age-related macular degeneration using the Lumithera Valeda Light Delivery System. Retina. 2024;44:487–97. https://doi.org/10.1097/IAE.0000000000003980.
Rodriguez DA, Song A, Bhatnagar A, Weng CY. Photobiomodulation therapy for non-exudative age-related macular degeneration. Int Ophthalmol Clin. 2025;65:47–52. https://doi.org/10.1097/IIO.0000000000000543.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Giraldo-Suarez, W.Y., Bonilla-Escobar, F.J. & Lozano-Cruz, E. Comment on: ‘Photobiomodulation-induced choriocapillaris perfusion enhancement and outer retinal remodelling in intermediate age-related macular degeneration: a promising therapeutic approach with short-term results’. Eye (2025). https://doi.org/10.1038/s41433-025-04177-3
Received:
Revised:
Accepted:
Published:
Version of record:
DOI: https://doi.org/10.1038/s41433-025-04177-3